223 related articles for article (PubMed ID: 9033274)
21. Correlation between intima-to-media ratio, apolipoprotein B-100, myeloperoxidase, and hypochlorite-oxidized proteins in human atherosclerosis.
Hazell LJ; Baernthaler G; Stocker R
Free Radic Biol Med; 2001 Nov; 31(10):1254-62. PubMed ID: 11705704
[TBL] [Abstract][Full Text] [Related]
22. Comparative reactivity of the myeloperoxidase-derived oxidants HOCl and HOSCN with low-density lipoprotein (LDL): Implications for foam cell formation in atherosclerosis.
Ismael FO; Proudfoot JM; Brown BE; van Reyk DM; Croft KD; Davies MJ; Hawkins CL
Arch Biochem Biophys; 2015 May; 573():40-51. PubMed ID: 25795019
[TBL] [Abstract][Full Text] [Related]
23. The IgM response to modified LDL in experimental atherosclerosis: hypochlorite-modified LDL IgM antibodies versus classical natural T15 IgM antibodies.
van Leeuwen M; Damoiseaux J; Duijvestijn A; Heeringa P; Gijbels M; de Winther M; Tervaert JW
Ann N Y Acad Sci; 2009 Sep; 1173():274-9. PubMed ID: 19758162
[TBL] [Abstract][Full Text] [Related]
24. Myeloperoxidase-dependent generation of hypochlorite-modified proteins in human placental tissues during normal pregnancy.
Hammer A; Desoye G; Dohr G; Sattler W; Malle E
Lab Invest; 2001 Apr; 81(4):543-54. PubMed ID: 11304574
[TBL] [Abstract][Full Text] [Related]
25. Effects of malondialdehyde content in low density lipoproteins on platelet adhesion.
Suttnar J; Otáhalová E; Cermák J; Dyr JE
Platelets; 2006 Mar; 17(2):92-9. PubMed ID: 16421010
[TBL] [Abstract][Full Text] [Related]
26. [Effect of hypochlorite and hydrogen peroxide on the ability of hemoglobin to stimulate lipid peroxidation of low density lipoproteins].
Osipov AN; Briukhanova EV; Vakhrusheva TV; Panasenko OM; Vladimirov IuA
Biofizika; 1997; 42(2):400-7. PubMed ID: 9172684
[TBL] [Abstract][Full Text] [Related]
27. Oxidative modification and nitration of human low-density lipoproteins by the reaction of hypochlorous acid with nitrite.
Panasenko OM; Briviba K; Klotz LO; Sies H
Arch Biochem Biophys; 1997 Jul; 343(2):254-9. PubMed ID: 9224738
[TBL] [Abstract][Full Text] [Related]
28. Effects of oxidation on the structure and stability of human low-density lipoprotein.
Jayaraman S; Gantz DL; Gursky O
Biochemistry; 2007 May; 46(19):5790-7. PubMed ID: 17444660
[TBL] [Abstract][Full Text] [Related]
29. Effect of hypochlorite (HOCl)-modified low density lipoproteins and high density lipoproteins on platelet function.
Opper C; Schüssler G; Sattler W; Malle E
Platelets; 1998; 9(5):339-41. PubMed ID: 16793758
[TBL] [Abstract][Full Text] [Related]
30. Characterization of non-covalent oligomers of proteins treated with hypochlorous acid.
Chapman AL; Winterbourn CC; Brennan SO; Jordan TW; Kettle AJ
Biochem J; 2003 Oct; 375(Pt 1):33-40. PubMed ID: 12852783
[TBL] [Abstract][Full Text] [Related]
31. Hydrogen sulphide: a novel physiological inhibitor of LDL atherogenic modification by HOCl.
Laggner H; Muellner MK; Schreier S; Sturm B; Hermann M; Exner M; Gmeiner BM; Kapiotis S
Free Radic Res; 2007 Jul; 41(7):741-7. PubMed ID: 17577734
[TBL] [Abstract][Full Text] [Related]
32. Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein(a).
Wanner C; Greiber S; Krämer-Guth A; Heinloth A; Galle J
Kidney Int Suppl; 1997 Dec; 63():S102-6. PubMed ID: 9407434
[TBL] [Abstract][Full Text] [Related]
33. Hypochlorite-modified low-density lipoprotein induces the apoptotic machinery in Jurkat T-cell lines.
Resch U; Semlitsch M; Hammer A; Susani-Etzerodt H; Walczak H; Sattler W; Malle E
Biochem Biophys Res Commun; 2011 Jul; 410(4):895-900. PubMed ID: 21708126
[TBL] [Abstract][Full Text] [Related]
34. Immune responses against fibronectin modified by lipoprotein oxidation and their association with cardiovascular disease.
Dunér P; To F; Alm R; Gonçalves I; Fredrikson GN; Hedblad B; Berglund G; Nilsson J; Bengtsson E
J Intern Med; 2009 May; 265(5):593-603. PubMed ID: 19226376
[TBL] [Abstract][Full Text] [Related]
35. Thiocyanate catalyzes myeloperoxidase-initiated lipid oxidation in LDL.
Exner M; Hermann M; Hofbauer R; Hartmann B; Kapiotis S; Gmeiner B
Free Radic Biol Med; 2004 Jul; 37(2):146-55. PubMed ID: 15203186
[TBL] [Abstract][Full Text] [Related]
36. Hypochlorous acid-mediated oxidation of lipid components and antioxidants present in low-density lipoproteins: absolute rate constants, product analysis, and computational modeling.
Pattison DI; Hawkins CL; Davies MJ
Chem Res Toxicol; 2003 Apr; 16(4):439-49. PubMed ID: 12703960
[TBL] [Abstract][Full Text] [Related]
37. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.
Hazen SL; Heinecke JW
J Clin Invest; 1997 May; 99(9):2075-81. PubMed ID: 9151778
[TBL] [Abstract][Full Text] [Related]
38. Copper ions and hydrogen peroxide form hypochlorite from NaCl thereby mimicking myeloperoxidase.
Frenkel K; Blum F; Troll W
J Cell Biochem; 1986; 30(3):181-93. PubMed ID: 3009503
[TBL] [Abstract][Full Text] [Related]
39. Impact of myeloperoxidase-LDL interactions on enzyme activity and subsequent posttranslational oxidative modifications of apoB-100.
Delporte C; Boudjeltia KZ; Noyon C; Furtmüller PG; Nuyens V; Slomianny MC; Madhoun P; Desmet JM; Raynal P; Dufour D; Koyani CN; Reyé F; Rousseau A; Vanhaeverbeek M; Ducobu J; Michalski JC; Nève J; Vanhamme L; Obinger C; Malle E; Van Antwerpen P
J Lipid Res; 2014 Apr; 55(4):747-57. PubMed ID: 24534704
[TBL] [Abstract][Full Text] [Related]
40. Comparison of low-density lipoprotein modification by myeloperoxidase-derived hypochlorous and hypobromous acids.
Carr AC; Decker EA; Park Y; Frei B
Free Radic Biol Med; 2001 Jul; 31(1):62-72. PubMed ID: 11425491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
